TG-100572

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTG-100572
Drug Alias NameTG-100572
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsTyrosine-protein kinase SRC inhibitorsEphrin type-B receptor 4 antagonists +[4] 
TargetsTyrosine-protein kinase SRCPlatelet-derived growth factor receptorVascular endothelial growth factor receptor +[4] 
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A